Search

Your search keyword '"Malih, Narges"' showing total 40 results
Start Over Author "Malih, Narges"
40 results on '"Malih, Narges"'

2. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Author

Wu, Ai-Min, Cross, Marita, Elliott, James M, Culbreth, Garland T, Haile, Lydia M, Steinmetz, Jaimie D, Hagins, Hailey, Kopec, Jacek A, Brooks, Peter M, Woolf, Anthony D, Kopansky-Giles, Deborah R, Walton, David M, Treleaven, Julia M, Dreinhoefer, Karsten E, Betteridge, Neil, Abbasifard, Mitra, Abbasi-Kangevari, Zeinab, Addo, Isaac Yeboah, Adesina, Miracle Ayomikun, Adnani, Qorinah Estiningtyas Sakilah, Aithala, Janardhana P, Alhalaiqa, Fadwa Alhalaiqa Naji, Alimohamadi, Yousef, Amiri, Sohrab, Amu, Hubert, Antony, Benny, Arabloo, Jalal, Aravkin, Aleksandr Y, Asghari-Jafarabadi, Mohammad, Atomsa, Gamechu Hunde, Azadnajafabad, Sina, Azzam, Ahmed Y, Baghdadi, Soroush, Balogun, Saliu A, Balta, Asaminew Birhanu, Banach, Maciej, Banakar, Morteza, Barrow, Amadou, Bashiri, Azadeh, Bekele, Alehegn, Bensenor, Isabela M, Bhardwaj, Pankaj, Bhat, Ajay Nagesh, Bilchut, Awraris Hailu, Briggs, Andrew M, Buchbinder, Rachelle, Cao, Chao, Chaurasia, Akhilanand, Chirinos-Caceres, Jesus Lorenzo, Christensen, Steffan Wittrup McPhee, Coberly, Kaleb, Cousin, Ewerton, Dadras, Omid, Dai, Xiaochen, de Luca, Katie, Dehghan, Azizallah, Dong, Huan-Ji, Ekholuenetale, Michael, Elhadi, Muhammed, Eshetu, Habitu Birhan, Eskandarieh, Sharareh, Etaee, Farshid, Fagbamigbe, Adeniyi Francis, Fares, Jawad, Fatehizadeh, Ali, Feizkhah, Alireza, Ferreira, Manuela L, Ferreira, Nuno, Fischer, Florian, Franklin, Richard Charles, Ganesan, Balasankar, Gebremichael, Mathewos Alemu, Gerema, Urge, Gholami, Ali, Ghozy, Sherief, Gill, Tiffany K, Golechha, Mahaveer, Goleij, Pouya, Golinelli, Davide, Graham, Simon Matthew, Haj-Mirzaian, Arvin, Harlianto, Netanja I, Hartvigsen, Jan, Hasanian, Mohammad, Hassen, Mohammed Bheser, Hay, Simon I, Hebert, Jeffrey J, Heidari, Golnaz, Hoveidaei, Amir Human, Hsiao, Alexander Kevin, Ibitoye, Segun Emmanuel, Iwu, Chidozie C D, Jacob, Louis, Janodia, Manthan Dilipkumar, Jin, Yingzhao, Jonas, Jost B., Joshua, Charity Ehimwenma, Kandel, Himal, Khader, Yousef Saleh, Khajuria, Himanshu, Khan, Ejaz Ahmad, Khan, Moien AB, Khatatbeh, Moawiah Mohammad, Khateri, Sorour, Khayat Kashani, Hamid Reza, Khonji, Mohammad Saeid, Khubchandani, Jagdish, Kim, Yun Jin, Kisa, Adnan, Kolahi, Ali-Asghar, Koohestani, Hamid Reza, Krishan, Kewal, Kuddus, Mohammed, Kuttikkattu, Ambily, Lasrado, Savita, Lee, Yo Han, Legesse, Samson Mideksa, Lim, Stephen S, Liu, Xuefeng, Lo, Justin, Malih, Narges, Manandhar, Shisir Prasad, Mathews, Elezebeth, Mesregah, Mohamed Kamal, Mestrovic, Tomislav, Miller, Ted R, Mirghaderi, Seyed Peyman, Misganaw, Awoke, Mohammadi, Esmaeil, Mohammed, Shafiu, Mokdad, Ali H, Momtazmanesh, Sara, Moni, Mohammad Ali, Mostafavi, Ebrahim, Murray, Christopher J L, Nair, Tapas Sadasivan, Nejadghaderi, Seyed Aria, Nzoputam, Ogochukwu Janet, Oh, In-Hwan, Okonji, Osaretin Christabel, Owolabi, Mayowa O, Pacheco-Barrios, Kevin, Pahlevan Fallahy, Mohammad Taha, Park, Seoyeon, Patel, Jay, Pawar, Shrikant, Pedersini, Paolo, Peres, Mario F P, Petcu, Ionela-Roxana, Pourahmadi, Mohammadreza, Qattea, Ibrahim, Ram, Pradhum, Rashidi, Mohammad-Mahdi, Rawaf, Salman, Rezaei, Nazila, Rezaei, Negar, Saeed, Umar, Saheb Sharif-Askari, Fatemeh, Salahi, Saina, Sawhney, Monika, Schumacher, Austin E, Shafie, Mahan, Shahabi, Saeed, Shahbandi, Ataollah, Shamekh, Ali, Sharma, Saurab, Shiri, Rahman, Shobeiri, Parnian, Sinaei, Ehsan, Singh, Ambrish, Singh, Jasvinder A., Singh, Paramdeep, Skryabina, Anna Aleksandrovna, Smith, Amanda E, Tabish, Mohammad, Tan, Ker-Kan, Tegegne, Masresha Derese, Tharwat, Samar, Vahabi, Seyed Mohammad, Valadan Tahbaz, Sahel, Vasankari, Tommi Juhani, Venketasubramanian, Narayanaswamy, Vollset, Stein Emil, Wang, Yuan-Pang, Wiangkham, Taweewat, Yonemoto, Naohiro, Zangiabadian, Moein, Zare, Iman, Zemedikun, Dawit T, Zheng, Peng, Ong, Kanyin Liane, Vos, Theo, and March, Lyn M

Published
2024
Full Text
View/download PDF

4. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Author

Ferreira, Manuela L, de Luca, Katie, Haile, Lydia M, Steinmetz, Jaimie D, Culbreth, Garland T, Cross, Marita, Kopec, Jacek A, Ferreira, Paulo H, Blyth, Fiona M, Buchbinder, Rachelle, Hartvigsen, Jan, Wu, Ai-Min, Safiri, Saeid, Woolf, Anthony D, Collins, Gary S, Ong, Kanyin Liane, Vollset, Stein Emil, Smith, Amanda E, Cruz, Jessica A, Fukutaki, Kai Glenn, Abate, Semagn Mekonnen, Abbasifard, Mitra, Abbasi-Kangevari, Mohsen, Abbasi-Kangevari, Zeinab, Abdelalim, Ahmed, Abedi, Aidin, Abidi, Hassan, Adnani, Qorinah Estiningtyas Sakilah, Ahmadi, Ali, Akinyemi, Rufus Olusola, Alamer, Abayneh Tadesse, Alem, Adugnaw Zeleke, Alimohamadi, Yousef, Alshehri, Mansour Abdullah, Alshehri, Mohammed Mansour, Alzahrani, Hosam, Amini, Saeed, Amiri, Sohrab, Amu, Hubert, Andrei, Catalina Liliana, Andrei, Tudorel, Antony, Benny, Arabloo, Jalal, Arulappan, Judie, Arumugam, Ashokan, Ashraf, Tahira, Athari, Seyyed Shamsadin, Awoke, Nefsu, Azadnajafabad, Sina, Bärnighausen, Till Winfried, Barrero, Lope H, Barrow, Amadou, Barzegar, Akbar, Bearne, Lindsay M, Bensenor, Isabela M, Berhie, Alemshet Yirga, Bhandari, Bharti Bhandari, Bhojaraja, Vijayalakshmi S, Bijani, Ali, Bodicha, Belay Boda Abule, Bolla, Srinivasa Rao, Brazo-Sayavera, Javier, Briggs, Andrew M, Cao, Chao, Charalampous, Periklis, Chattu, Vijay Kumar, Cicuttini, Flavia M, Clarsen, Benjamin, Cuschieri, Sarah, Dadras, Omid, Dai, Xiaochen, Dandona, Lalit, Dandona, Rakhi, Dehghan, Azizallah, Demie, Takele Gezahegn G, Denova-Gutiérrez, Edgar, Dewan, Syed Masudur Rahman, Dharmaratne, Samath Dhamminda, Dhimal, Mandira Lamichhane, Dhimal, Meghnath, Diaz, Daniel, Didehdar, Mojtaba, Digesa, Lankamo Ena, Diress, Mengistie, Do, Hoa Thi, Doan, Linh Phuong, Ekholuenetale, Michael, Elhadi, Muhammed, Eskandarieh, Sharareh, Faghani, Shahriar, Fares, Jawad, Fatehizadeh, Ali, Fetensa, Getahun, Filip, Irina, Fischer, Florian, Franklin, Richard Charles, Ganesan, Balasankar, Gemeda, Belete Negese Belete, Getachew, Motuma Erena, Ghashghaee, Ahmad, Gill, Tiffany K, Golechha, Mahaveer, Goleij, Pouya, Gupta, Bhawna, Hafezi-Nejad, Nima, Haj-Mirzaian, Arvin, Hamal, Pawan Kumar, Hanif, Asif, Harlianto, Netanja I, Hasani, Hamidreza, Hay, Simon I, Hebert, Jeffrey J, Heidari, Golnaz, Heidari, Mohammad, Heidari-Soureshjani, Reza, Hlongwa, Mbuzeleni Mbuzeleni, Hosseini, Mohammad-Salar, Hsiao, Alexander Kevin, Iavicoli, Ivo, Ibitoye, Segun Emmanuel, Ilic, Irena M, Ilic, Milena D, Islam, Sheikh Mohammed Shariful, Janodia, Manthan Dilipkumar, Jha, Ravi Prakash, Jindal, Har Ashish, Jonas, Jost B, Kabito, Gebisa Guyasa, Kandel, Himal, Kaur, Rimple Jeet, Keshri, Vikash Ranjan, Khader, Yousef Saleh, Khan, Ejaz Ahmad, Khan, Md Jobair, Khan, Moien AB, Khayat Kashani, Hamid Reza, Khubchandani, Jagdish, Kim, Yun Jin, Kisa, Adnan, Klugarová, Jitka, Kolahi, Ali-Asghar, Koohestani, Hamid Reza, Koyanagi, Ai, Kumar, G Anil, Kumar, Narinder, Lallukka, Tea, Lasrado, Savita, Lee, Wei-Chen, Lee, Yo Han, Mahmoodpoor, Ata, Malagón-Rojas, Jeadran N, Malekpour, Mohammad-Reza, Malekzadeh, Reza, Malih, Narges, Mehndiratta, Man Mohan, Mehrabi Nasab, Entezar, Menezes, Ritesh G, Mentis, Alexios-Fotios A, Mesregah, Mohamed Kamal, Miller, Ted R, Mirza-Aghazadeh-Attari, Mohammad, Mobarakabadi, Maryam, Mohammad, Yousef, Mohammadi, Esmaeil, Mohammed, Shafiu, Mokdad, Ali H, Momtazmanesh, Sara, Monasta, Lorenzo, Moni, Mohammad Ali, Mostafavi, Ebrahim, Murray, Christopher J L, Nair, Tapas Sadasivan, Nazari, Javad, Nejadghaderi, Seyed Aria, Neupane, Subas, Neupane Kandel, Sandhya, Nguyen, Cuong Tat, Nowroozi, Ali, Okati-Aliabad, Hassan, Omer, Emad, Oulhaj, Abderrahim, Owolabi, Mayowa O, Panda-Jonas, Songhomitra, Pandey, Anamika, Park, Eun-Kee, Pawar, Shrikant, Pedersini, Paolo, Pereira, Jeevan, Peres, Mario F P, Petcu, Ionela-Roxana, Pourahmadi, Mohammadreza, Radfar, Amir, Rahimi-Dehgolan, Shahram, Rahimi-Movaghar, Vafa, Rahman, Mosiur, Rahmani, Amir Masoud, Rajai, Nazanin, Rao, Chythra R, Rashedi, Vahid, Rashidi, Mohammad-Mahdi, Ratan, Zubair Ahmed, Rawaf, David Laith, Rawaf, Salman, Renzaho, Andre M N, Rezaei, Negar, Rezaei, Zahed, Roever, Leonardo, Ruela, Guilherme de Andrade, Saddik, Basema, Sahebkar, Amirhossein, Salehi, Sana, Sanmarchi, Francesco, Sepanlou, Sadaf G, Shahabi, Saeed, Shahrokhi, Shayan, Shaker, Elaheh, Shamsi, MohammadBagher, Shannawaz, Mohammed, Sharma, Saurab, Shaygan, Maryam, Sheikhi, Rahim Ali, Shetty, Jeevan K, Shiri, Rahman, Shivalli, Siddharudha, Shobeiri, Parnian, Sibhat, Migbar Mekonnen, Singh, Ambrish, Singh, Jasvinder A, Slater, Helen, Solmi, Marco, Somayaji, Ranjani, Tan, Ker-Kan, Thapar, Rekha, Tohidast, Seyed Abolfazl, Valadan Tahbaz, Sahel, Valizadeh, Rohollah, Vasankari, Tommi Juhani, Venketasubramanian, Narayanaswamy, Vlassov, Vasily, Vo, Bay, Wang, Yuan-Pang, Wiangkham, Taweewat, Yadav, Lalit, Yadollahpour, Ali, Yahyazadeh Jabbari, Seyed Hossein, Yang, Lin, Yazdanpanah, Fereshteh, Yonemoto, Naohiro, Younis, Mustafa Z, Zare, Iman, Zarrintan, Armin, Zoladl, Mohammad, Vos, Theo, and March, Lyn M

Published
2023
Full Text
View/download PDF

5. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study

Author

Malekpour, Mohammad-Reza, Abbasi-Kangevari, Mohsen, Ghamari, Seyyed-Hadi, Khanali, Javad, Heidari-Foroozan, Mahsa, Moghaddam, Sahar Saeedi, Azangou-Khyavy, Mohammadreza, Rezazadeh-Khadem, Sahba, Rezaei, Negar, Shobeiri, Parnian, Esfahani, Zahra, Rezaei, Nazila, Aali, Amirali, Abd-Elsalam, Sherief, Abdoun, Meriem, Absalan, Abdorrahim, Abu-Gharbieh, Eman, Abu-Rmeileh, Niveen ME., Abu-Zaid, Ahmed, Ahmadi, Ali, Ahmadi, Sepideh, Ahmed, Ayman, Rashid, Tarik Ahmed, Ajami, Marjan, Akbarzadeh-Khiavi, Mostafa, Al Hamad, Hanadi, Alalwan, Tariq A., Alhabib, Khalid F., Alimohamadi, Yousef, Alipour, Vahid, Aljunid, Syed Mohamed, Alomari, Mahmoud A., Alqahatni, Saleh A., Al-Raddadi, Rajaa M., Aminian Dehkordi, Javad Javad, Amir-Behghadami, Mehrdad, Amiri, Sohrab, Anvari, Davood, Arabloo, Jalal, Arulappan, Judie, Arumugam, Ashokan, Aryan, Zahra, Athar, Mohammad, Athari, Seyyed Shamsadin, Avan, Abolfazl, Azadnajafabad, Sina, Azari, Samad, Azizi, Hosein, Baghcheghi, Nayereh, Bagheri, Nader, Bagherieh, Sara, Baltatu, Ovidiu Constantin, Bhagavathula, Akshaya Srikanth, Bhojaraja, Vijayalakshmi S., Bouaoud, Souad, Butt, Muhammad Hammad, Campos, Luciana Aparecida, Chitheer, Abdulaal, Cheshmeh Soltani, Reza Darvishi, Darwesh, Aso Mohammad, Djalalinia, Shirin, Dodangeh, Milad, El Sayed Zaki, Maysaa, Elbarazi, Iffat, Elhadi, Muhammed, El-Huneidi, Waseem, Ezzeddini, Rana, Fareed, Mohammad, Farrokhpour, Hossein, Fatehizadeh, Ali, Galali, Yaseen, Ghaderi, Amir, Ghafourifard, Mansour, Nour, Mohammad Ghasemi, Ghashghaee, Ahmad, Gholamalizadeh, Maryam, Goleij, Pouya, Golitaleb, Mohamad, Habibzadeh, Parham, Hafezi-Nejad, Nima, Halwani, Rabih, Hasani, Hamidreza, Hashemian, Maryam, Hassan, Amr, Hassanipour, Soheil, Hassankhani, Hadi, Hezam, Kamal, Homayounfar, Reza, Hosseini, Seyed Kianoosh, Hosseini, Kaveh, Hosseinzadeh, Mehdi, Hoveidamanesh, Soodabeh, Jaafari, Jalil, Jahrami, Haitham, Jamshidi, Elham, Javaheri, Tahereh, Jayapal, Sathish Kumar, Kabir, Ali, Karimi, Amirali, Kaydi, Neda, Keykhaei, Mohammad, Khader, Yousef Saleh, Khafaie, Morteza Abdullatif, Khan, Moien A.B., Khan, Kashif Ullah, Khan, Yusra H., Khatatbeh, Moawiah Mohammad, Kompani, Farzad, Koohestani, Hamid Reza, Kuddus, Mohammed, Lasrado, Savita, Lee, Sang-woong, Mahjoub, Soleiman, Mahmoodpoor, Ata, Mahmoudi, Elham, Rad, Elaheh Malakan, Malih, Narges, Malik, Ahmad Azam, Mallhi, Tauqeer Hussain, Manla, Yosef, Mansouri, Borhan, Mansournia, Mohammad Ali, Mardi, Parham, Marjani, Abdoljalal, Masoudi, Sahar, Nasab, Entezar Mehrabi, Menezes, Ritesh G., Mevsim, Vildan, Mohammad, Yousef, Mohammadi, Mokhtar, Mohammadi, Esmaeil, Mohammadifard, Noushin, Mohammed, Arif, Momtazmanesh, Sara, Montazeri, Fateme, Moradi, Maryam, Moradi-Lakeh, Maziar, Morovatdar, Negar, Murray, Christopher J.L., Natto, Zuhair S., Nejadghaderi, Seyed Aria, Nowroozi, Ali, Oladnabi, Morteza, Bali, Ahmed Omar, Omer, Emad, Toroudi, Hamidreza Pazoki, Pezzani, Raffaele, Langroudi, Ashkan Pourabhari, Rafiei, Sima, Rahimi, Mehran, Rahimi-Movaghar, Vafa, Rahmani, Shayan, Rahmani, Amir Masoud, Rahmanian, Vahid, Rao, Chythra R., Rashedi, Sina, Rashidi, Mohammad-Mahdi, Rawassizadeh, Reza, Mohamed Redwan, Elrashdy Moustafa, Rezaee, Malihe, Rezaei, Maryam, Riahi, Seyed Mohammad, Roshandel, Gholamreza, Saad, Aly, Saber-Ayad, Maha Mohamed, Sabour, Siamak, Sabzmakan, Leila, Saddik, Basema, Sadeghi, Erfan, Sadeghian, Saeid, Sahebkar, Amirhossein, Saki, Morteza, Salahi, Saina, Salahi, Sarvenaz, Farrokhi, Amir Salek, Salem, Marwa Rashad, Salimzadeh, Hamideh, Samy, Abdallah M., Sarrafzadegan, Nizal, Sathian, Brijesh, Shafeghat, Melika, Shah, Syed Mahboob, Shah, Jaffer, Shahbandi, Ataollah, Shahraki-Sanavi, Fariba, Shams-Beyranvand, Mehran, Shanawaz, Mohd, Sharafi, Kiomars, Sharifi-Rad, Javad, Shetty, Jeevan K., Varniab, Zahra Shokri, Shorofi, Seyed Afshin, Siabani, Soraya, Soltani-Zangbar, Mohammad Sadegh, Tabaeian, Seidamir Pasha, Tabatabaeizadeh, Seyed-Amir, Tabish, Mohammad, Taheri, Majid, Abkenar, Yasaman Taheri, Soodejani, Moslem Taheri, Taherkhani, Amir, Tehrani-Banihashemi, Arash, Temsah, Mohamad-Hani, Tigabu, Bereket M., Vakilian, Alireza, Vaziri, Siavash, Vo, Bay, Yazdanpanah, Fereshteh, Yigit, Arzu, Yiğit, Vahit, Zahir, Mazyar, Zaman, Burhan Abdullah, Zamanian, Maryam, Zangiabadian, Moein, Zare, Iman, Zareshahrabadi, Zahra, Mokdad, Ali H., Naghavi, Mohsen, Larijani, Bagher, and Farzadfar, Farshad

Published
2023
Full Text
View/download PDF

6. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

Author

Awedew, Atalel Fentahun, Han, Hannah, Abbasi, Behzad, Abbasi-Kangevari, Mohsen, Ahmed, Muktar Beshir, Almidani, Omar, Amini, Erfan, Arabloo, Jalal, Argaw, Ayele Mamo, Athari, Seyyed Shamsadin, Atlaw, Daniel, Banach, Maciej, Barrow, Amadou, Bhagavathula, Akshaya Srikanth, Bhojaraja, Vijayalakshmi S, Bikbov, Boris, Bodicha, Belay Boda Abule, Butt, Nadeem Shafique, Caetano dos Santos, Florentino Luciano, Dadras, Omid, Dai, Xiaochen, Doan, Linh Phuong, Eftekharzadeh, Sahar, Fatehizadeh, Ali, Garg, Tushar, Gebremeskel, Teferi Gebru, Getachew, Motuma Erena, Ghamari, Seyyed-Hadi, Gilani, Syed Amir, Golechha, Mahaveer, Gupta, Veer Bala, Gupta, Vivek Kumar, Hay, Simon I, Hosseini, Mohammad-Salar, Hosseinzadeh, Mehdi, Humayun, Ayesha, Ilic, Irena M, Ilic, Milena D, Ismail, Nahlah Elkudssiah, Jakovljevic, Mihajlo, Jayaram, Shubha, Jazayeri, Seyed Behzad, Jema, Alelign Tasew, Kabir, Ali, Karaye, Ibraheem M, Khader, Yousef Saleh, Khan, Ejaz Ahmad, Landires, Iván, Lee, Sang-woong, Lee, Shaun Wen Huey, Lim, Stephen S, Lobo, Stany W, Majeed, Azeem, Malekpour, Mohammad-Reza, Malih, Narges, Malik, Ahmad Azam, Mehrabi Nasab, Entezar, Mestrovic, Tomislav, Michalek, Irmina Maria, Mihrtie, Gedefaye Nibret, Mirza-Aghazadeh-Attari, Mohammad, Misganaw, Awoke Temesgen, Mokdad, Ali H, Molokhia, Mariam, Murray, Christopher J L, Narasimha Swamy, Sreenivas, Nguyen, Son Hoang, Nowroozi, Ali, Nuñez-Samudio, Virginia, Owolabi, Mayowa O, Pawar, Shrikant, Perico, Norberto, Rawaf, David Laith, Rawaf, Salman, Rawassizadeh, Reza, Remuzzi, Giuseppe, Sahebkar, Amirhossein, Sampath, Chethan, Shetty, Jeevan K, Sibhat, Migbar Mekonnen, Singh, Jasvinder A, Tan, Ker-Kan, Temesgen, Gebremaryam, Tolani, Musliu Adetola, Tovani-Palone, Marcos Roberto, Valadan Tahbaz, Sahel, Valizadeh, Rohollah, Vo, Bay, Vu, Linh Gia, Yang, Lin, Yazdanpanah, Fereshteh, Yigit, Arzu, Yiğit, Vahit, Yunusa, Ismaeel, Zahir, Mazyar, Vos, Theo, and Dirac, M Ashworth

Published
2022
Full Text
View/download PDF

8. Preparatory work for the safety evaluation by EFSA of Human‐identical Milk Oligosaccharides as Novel Foods.

Author

Malih, Narges, Konieczna, Jadwiga, Fernandez, Mar Nafria, Fiol‐deRoque, Maria Antonia, Zamanillo‐Campos, Rocío, and Ricci‐Cabello, Ignacio

Subjects
*OLIGOSACCHARIDES, *MILK analysis, *FOOD industry
Abstract

Background and aims: This report describes a scoping literature review as preparatory work for the safety evaluation by EFSA of Human‐identical Milk Oligosaccharides (HiMOs) as Novel Foods (NFs). The main objective was to gather information on the concentrations of Human Milk Oligosaccharides (HMOs) in human milk, both individual and total, and the combinations/mixtures of HiMOs/HMOs in commercially available products or those reported in the literature. Methods: A scoping literature review was conducted, including a search strategy implemented in biomedical (PubMed) and multidisciplinary (Web of Science) databases from 2013 to March 2024, supplemented by an ad hoc search for primary studies included in two key recent systematic reviews and grey literature searches on relevant food business operators' websites. Both primary and secondary studies were selected to determine the individual concentrations of target HMOs, the total concentration of HMOs and relevant HMO fractions, and the combinations/mixtures of HiMOs/HMOs. Only studies with full text published in English or Spanish were eligible, excluding patents, editorials, conference abstracts, books, and dissertations. Results: The structured searches yielded 2,851 unique references, with 218 selected for full‐text evaluation and 36 additional unique references from the key systematic reviews. Ultimately, 171 publications were included in the review. Fourteen companies related to HiMOs were identified through grey literature. In most publications, concentration data for multiple groups of donors (e.g., based on factors like secretor status or lactation period) were reported. By groups of donors, the mean total concentration of HMOs in milk (excluding colostrum) was 6,740 mg/L, whereas the mean by publication was 5,341 mg/L. By publication, the mean concentrations of individual HMOs (mg/L, excluding colostrum) were: LNnT 288, LNT 971, 2'‐FL 1,468, 3‐FL 800, DFL 232, 3'‐SL 212, 6'‐SL 365, LNFP I 738, and LNT/LNnT 611. By groups of donors, the mean concentrations (mg/L, excluding colostrum) were: LNnT 382, LNT 1064.1, 2'‐FL 1685, 3‐FL 907, DFL 303, 3'‐SL 225, 6'‐SL 435, LNFP I 773, and LNT/LNnT 882. By publication, the mean concentration (mg/L) of groups of HMOs mean concentrations (excluding colostrum) was: 4,577 for total neutral; 851 for total acidic; 4,635 for total acidic fucosylated; 1,631 for α‐1‐3/4‐fucosylated; 3,304 for α‐1‐2‐fucosylated; 1,601 for non‐fucosylated; 1,505 for total sialyllated; 2,293 for acidic sialyllated. By group of donors, the mean concentration (mg/L) of groups of HMOs mean concentrations (excluding colostrum) was: 3,942 for total neutral; 1,032 for total acidic; 6,477 for total acidic fucosylated; 1,650 for α‐1‐3/4‐fucosylated; 3,748 for α‐1‐2‐fucosylated; 2,026 for non‐fucosylated; 1,957 for total sialyllated; 2,293 for acidic sialyllated. The most frequent combinations of HMOs/HiMOs were LNnT + 2'‐FL (24 products, 32%) and 2'‐FL + 3'‐SL (12 products, 16%). Conclusions: The findings of this review will support EFSA in the safety evaluation of HiMOs as NFs, in accordance with the EC mandate (M‐2023‐00157). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Reporting of participant race and ethnicity from COVID-19 randomized controlled drug and biologicals trials: a scoping review

Author

Pranić, Shelly Melissa, primary, Estevão, Maria Dulce, additional, Vasanthan, Lenny T., additional, Pérez-Neri, Iván, additional, Pulumati, Anika, additional, Junior, Fábio Antonio Serra de Lima, additional, Malih, Narges, additional, Mishra, Vinayak, additional, Thompson, Jacqueline, additional, and Nnate, Daniel, additional

Published
2024
Full Text
View/download PDF

11. Frequency of use and adequacy of Cochrane risk of bias tool 2 in non‐Cochrane systematic reviews published in 2020: Meta‐research study

Author

Babić, Andrija, primary, Barcot, Ognjen, additional, Visković, Tomislav, additional, Šarić, Frano, additional, Kirkovski, Aleksandar, additional, Barun, Ivana, additional, Križanac, Zvonimir, additional, Ananda, Roshan Arjun, additional, Fuentes Barreiro, Yuli Viviana, additional, Malih, Narges, additional, Dimcea, Daiana Anne‐Marie, additional, Ordulj, Josipa, additional, Weerasekara, Ishanka, additional, Spezia, Matteo, additional, Žuljević, Marija Franka, additional, Šuto, Jelena, additional, Tancredi, Luca, additional, Pijuk, Anđela, additional, Sammali, Susanna, additional, Iascone, Veronica, additional, von Groote, Thilo, additional, Poklepović Peričić, Tina, additional, and Puljak, Livia, additional

Published
2024
Full Text
View/download PDF

13. The global epidemiology of Microsporidia infection in birds: A systematic review and meta-analysis.

Author

Taghipour, Ali, Ghodsian, Sahar, Jabbari, Mahdi, Rajabpour, Vahid, Bahadory, Saeed, Malih, Narges, Solhjoo, Kavous, Zibaei, Mohammad, and Abdoli, Amir

Subjects
MYCOSES, RESEARCH funding, POLYMERASE chain reaction, META-analysis, FUNGI, WORLD health, GENETIC variation, BIRDS, SYSTEMATIC reviews, MEDLINE, ANIMAL experimentation, CONFIDENCE intervals, MICROSCOPY, ONLINE information services, GENOTYPES
Abstract

This study aimed to assess the global status and genetic diversity of Microsporidia infection in different birds. An online search was conducted in international databases from 1 January 1990 to 30 June 2022. A total of 34 articles (including 37 datasets) were included for the final meta-analysis. The pooled global prevalence of Microsporidia infection in birds was 14.6% (95% CI: 11.6–18.1). The highest prevalence of Microsporidia was found in wild waterfowl which was 54.5% (28.1–78.6). In terms of detection methods, the pooled prevalence was estimated to be 21.2% (95% CI: 12.1–34.4) and 13.4% (95% CI: 10.3–17.3) for using microscopic and molecular detection methods, respectively. Enterocytozoon bieneusi was the most common pathogen (24/31; 77.42% of the studies) according to PCR-based methods, and genotype D was the highest reported genotype (nine studies). In conclusion, designing strategies for the control and prevention of Microsporidia infection in birds should be recommended. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study

Author

Mahmoodpoor, Ata, Dodangeh, Milad, El Sayed Zaki, Maysaa, Elbarazi, Iffat, Elhadi, Muhammed, El-Huneidi, Waseem, Ezzeddini, Rana, Fareed, Mohammad, Hassanipour, Soheil, Hassankhani, Hadi, Hezam, Kamal, Homayounfar, Reza, Salem, Marwa Rashad, Farrokhi, Amir Salek, Salahi, Sarvenaz, Salahi, Saina, Saki, Morteza, Sahebkar, Amirhossein, Sadeghian, Saeid, Sadeghi, Erfan, Saddik, Basema, Sabzmakan, Leila, Sabour, Siamak, Saber-Ayad, Maha Mohamed, Saad, Aly, Roshandel, Gholamreza, Riahi, Seyed Mohammad, Rezaei, Maryam, Rezaee, Malihe, Mohamed Redwan, Elrashdy Moustafa, Rawassizadeh, Reza, Rashidi, Mohammad-Mahdi, Rashedi, Sina, Rao, Chythra R., Rahmanian, Vahid, Rahmani, Amir Masoud, Rahmani, Shayan, Rahimi-Movaghar, Vafa, Rahimi, Mehran, Rafiei, Sima, Langroudi, Ashkan Pourabhari, Pezzani, Raffaele, Toroudi, Hamidreza Pazoki, Omer, Emad, Bali, Ahmed Omar, Oladnabi, Morteza, Nowroozi, Ali, Nejadghaderi, Seyed Aria, Natto, Zuhair S., Murray, Christopher J.L., Morovatdar, Negar, Moradi-Lakeh, Maziar, Moradi, Maryam, Montazeri, Fateme, Momtazmanesh, Sara, Mohammed, Arif, Mohammadifard, Noushin, Mohammadi, Esmaeil, Mohammadi, Mokhtar, Mohammad, Yousef, Mevsim, Vildan, Menezes, Ritesh G., Nasab, Entezar Mehrabi, Masoudi, Sahar, Marjani, Abdoljalal, Mardi, Parham, Mansournia, Mohammad Ali, Farrokhpour, Hossein, Fatehizadeh, Ali, Galali, Yaseen, Ghaderi, Amir, Ghafourifard, Mansour, Nour, Mohammad Ghasemi, Ghashghaee, Ahmad, Gholamalizadeh, Maryam, Goleij, Pouya, Golitaleb, Mohamad, Habibzadeh, Parham, Hafezi-Nejad, Nima, Halwani, Rabih, Hasani, Hamidreza, Hashemian, Maryam, Moghaddam, Sahar Saeedi, Azangou-Khyavy, Mohammadreza, Rezazadeh-Khadem, Sahba, Rezaei, Negar, Shobeiri, Parnian, Esfahani, Zahra, Rezaei, Nazila, Mokdad, Ali H., Naghavi, Mohsen, Larijani, Bagher, Farzadfar, Farshad, Heidari-Foroozan, Mahsa, Khanali, Javad, Ghamari, Seyyed-Hadi, Zareshahrabadi, Zahra, Zare, Iman, Zangiabadian, Moein, Abbasi-Kangevari, Mohsen, Malekpour, Mohammad-Reza, Zamanian, Maryam, Zaman, Burhan Abdullah, Zahir, Mazyar, Yiğit, Vahit, Yigit, Arzu, Yazdanpanah, Fereshteh, Vo, Bay, Vaziri, Siavash, Vakilian, Alireza, Tigabu, Bereket M., Aali, Amirali, Temsah, Mohamad-Hani, Tehrani-Banihashemi, Arash, Taherkhani, Amir, Soodejani, Moslem Taheri, Abkenar, Yasaman Taheri, Taheri, Majid, Tabish, Mohammad, Tabatabaeizadeh, Seyed-Amir, Tabaeian, Seidamir Pasha, Abd-Elsalam, Sherief, Abdoun, Meriem, Absalan, Abdorrahim, Abu-Gharbieh, Eman, Abu-Rmeileh, Niveen Me., Abu-Zaid, Ahmed, Ahmadi, Ali, Soltani-Zangbar, Mohammad Sadegh, Siabani, Soraya, Ahmadi, Sepideh, Ahmed, Ayman, Rashid, Tarik Ahmed, Ajami, Marjan, Akbarzadeh-Khiavi, Mostafa, Al Hamad, Hanadi, Alalwan, Tariq A., Alhabib, Khalid F., Alimohamadi, Yousef, Alipour, Vahid, Aljunid, Syed Mohamed, Alomari, Mahmoud A., Alqahatni, Saleh A., Al-Raddadi, Rajaa M., Aminian Dehkordi, Javad Javad, Amir-Behghadami, Mehrdad, Amiri, Sohrab, Anvari, Davood, Arabloo, Jalal, Arulappan, Judie, Arumugam, Ashokan, Aryan, Zahra, Hosseini, Seyed Kianoosh, Hosseini, Kaveh, Javaheri, Tahereh, Mansouri, Borhan, Manla, Yosef, Mallhi, Tauqeer Hussain, Malik, Ahmad Azam, Malih, Narges, Rad, Elaheh Malakan, Mahmoudi, Elham, Mahjoub, Soleiman, Lee, Sang-Woong, Lasrado, Savita, Kuddus, Mohammed, Koohestani, Hamid Reza, Kompani, Farzad, Khatatbeh, Moawiah Mohammad, Khan, Yusra H., Jamshidi, Elham, Khan, Kashif Ullah, Khan, Moien A.B., Jahrami, Haitham, Khafaie, Morteza Abdullatif, Khader, Yousef Saleh, Hosseinzadeh, Mehdi, Hoveidamanesh, Soodabeh, Jaafari, Jalil, Keykhaei, Mohammad, Kaydi, Neda, Karimi, Amirali, Athar, Mohammad, Athari, Seyyed Shamsadin, Avan, Abolfazl, Azadnajafabad, Sina, Azari, Samad, Azizi, Hosein, Kabir, Ali, Jayapal, Sathish Kumar, Hassan, Amr, Shorofi, Seyed Afshin, Varniab, Zahra Shokri, Baghcheghi, Nayereh, Bagheri, Nader, Bagherieh, Sara, Baltatu, Ovidiu Constantin, Bhagavathula, Akshaya Srikanth, Bhojaraja, Vijayalakshmi S., Bouaoud, Souad, Shetty, Jeevan K., Sharifi-Rad, Javad, Sharafi, Kiomars, Shanawaz, Mohd, Shams-Beyranvand, Mehran, Shahraki-Sanavi, Fariba, Shahbandi, Ataollah, Butt, Muhammad Hammad, Campos, Luciana Aparecida, Chitheer, Abdulaal, Cheshmeh Soltani, Reza Darvishi, Darwesh, Aso Mohammad, Djalalinia, Shirin, Shah, Jaffer, Shah, Syed Mahboob, Shafeghat, Melika, Sathian, Brijesh, Sarrafzadegan, Nizal, Samy, Abdallah M., and Salimzadeh, Hamideh

Published
2023

19. The global epidemiology of Microsporidia infection in birds: A systematic review and meta-analysis

Author

Taghipour, Ali, Ghodsian, Sahar, Jabbari, Mahdi, Rajabpour, Vahid, Bahadory, Saeed, Malih, Narges, Solhjoo, Kavous, Zibaei, Mohammad, and Abdoli, Amir

Abstract

This study aimed to assess the global status and genetic diversity of Microsporidia infection in different birds. An online search was conducted in international databases from 1 January 1990 to 30 June 2022. A total of 34 articles (including 37 datasets) were included for the final meta-analysis. The pooled global prevalence of Microsporidia infection in birds was 14.6% (95% CI: 11.6–18.1). The highest prevalence of Microsporidia was found in wild waterfowl which was 54.5% (28.1–78.6). In terms of detection methods, the pooled prevalence was estimated to be 21.2% (95% CI: 12.1–34.4) and 13.4% (95% CI: 10.3–17.3) for using microscopic and molecular detection methods, respectively. Enterocytozoon bieneusi was the most common pathogen (24/31; 77.42% of the studies) according to PCR-based methods, and genotype D was the highest reported genotype (nine studies). In conclusion, designing strategies for the control and prevention of Microsporidia infection in birds should be recommended.

Published
2023
Full Text
View/download PDF

20. Development and Evaluation of a Digital Health Intervention to Prevent Type 2 Diabetes in Primary Care: The PREDIABETEXT Study Protocol for a Randomised Clinical Trial

Author

Galmes-Panades, Aina M., primary, Angullo, Escarlata, additional, Mira-Martínez, Sofía, additional, Bennasar-Veny, Miquel, additional, Zamanillo-Campos, Rocío, additional, Gómez-Juanes, Rocío, additional, Konieczna, Jadwiga, additional, Jiménez, Rafael, additional, Serrano-Ripoll, Maria Jesús, additional, Fiol-deRoque, Maria Antonia, additional, Miralles, Jerónima, additional, Yañez, Aina M., additional, Romaguera, Dora, additional, Vidal-Thomas, Maria Clara, additional, Llobera-Canaves, Joan, additional, García-Toro, Mauro, additional, Vicens, Catalina, additional, Gervilla-García, Elena, additional, Oña, José Iván, additional, Malih, Narges, additional, Leiva, Alfonso, additional, Bulilete, Oana, additional, Montaño, Juan José, additional, Gili, Margalida, additional, Roca, Miquel, additional, and Ricci-Cabello, Ignacio, additional

Published
2022
Full Text
View/download PDF

21. Protocol of a scoping review of COVID-19 randomized controlled drug and biologicals trials reporting participant race

Author

Pranic, Shelly, Pérez-Neri, Iván, Estevao, Dulce, Vasanthan, Lenny, de Lima Junior, Fabio, Pulumati, Anika, Malih, Narges, Thompson, Jacqueline, Nnate, Daniel, and Mishra, Vinayak

Subjects
Bioethics and Medical Ethics, Medicine and Health Sciences, Medical Specialties, Infectious Disease, Public Health
Abstract

Protocol for a scoping review to summarize the reporting of race as a demographic variable from randomized controlled trials (RCTs) of drug or biological therapeutics for COVID-19. Additionally, we will determine the association between reported race and RCT characteristics.

Published
2022
Full Text
View/download PDF

22. Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

Author

Al-Hajj, Samar, primary, Farran, Sarah H, additional, Sibai, Abla Mehio, additional, Hamadeh, Randah R, additional, Rahimi-Movaghar, Vafa, additional, Al-Raddadi, Rajaa M, additional, Sadeghian, Farideh, additional, Ghodsi, Zahra, additional, Alhajyaseen, Wael, additional, Abu-Rmeileh, Niveen ME, additional, Abbasi, Behzad, additional, Abbasi-Kangevari, Mohsen, additional, Abdoli, Amir, additional, Abdulrahman, Salam Abdulqadir, additional, Abubaker Ali, Hiwa, additional, Abu-Gharbieh, Eman, additional, Afzal, Muhammad Sohail, additional, Ahadinezhad, Bahman, additional, Ahmad, Sajjad, additional, Ahmadi, Ali, additional, Ahmed, Ali, additional, Ahmed, Haroon, additional, Ahmed Rashid, Tarik, additional, Ajami, Marjan, additional, Al Hamad, Hanadi, additional, Alanezi, Fahad Mashhour, additional, Alanzi, Turki M, additional, Alghnam, Suliman A, additional, Alhalaiqa, Fadwa Naji, additional, Ali, Beriwan Abdulqadir, additional, Ali, Liaqat, additional, Alimohamadi, Yousef, additional, Alinia, Cyrus, additional, Aljunid, Syed Mohamed, additional, Almustanyir, Sami, additional, Amin, Tarek Tawfik, additional, Amini, Saeed, additional, Amiri, Sohrab, additional, Amirzade-Iranaq, Mohammad Hosein, additional, Anoushirvani, Ali Arash, additional, Ansari-Moghaddam, Alireza, additional, Anvari, Davood, additional, Aqeel, Muhammad, additional, Arabloo, Jalal, additional, Arab-Zozani, Morteza, additional, Arulappan, Judie, additional, Aryannejad, Armin, additional, Asgary, Saeed, additional, Asghari-Jafarabadi, Mohammad, additional, Ashraf, Tahira, additional, Athari, Seyyed Shamsadin, additional, Atout, Maha Moh'd Wahbi, additional, Azadmanjir, Zahra, additional, Azadnajafabad, Sina, additional, Azangou-Khyavy, Mohammadreza, additional, Azari Jafari, Amirhossein, additional, Azzam, Ahmed Y Y, additional, Bagherieh, Sara, additional, Bakhshaei, Mohammad Hossein, additional, Batiha, Abdul-Monim Mohammad, additional, Bedi, Neeraj, additional, Bhagavathula, Akshaya Srikanth, additional, Bhutta, Zulfiqar A, additional, Bibi, Sadia, additional, Bijani, Ali, additional, Butt, Nadeem Shafique, additional, Chegini, Zahra, additional, Da'ar, Omar B, additional, Dahlawi, Saad M A, additional, Delavari, Sajad, additional, Dianatinasab, Mostafa, additional, Didehdar, Mojtaba, additional, Djalalinia, Shirin, additional, Doaei, Saeid, additional, Dodangeh, Milad, additional, Eghbalian, Fatemeh, additional, Ehsani-Chimeh, Elham, additional, El Sayed, Iman, additional, El Sayed Zaki, Maysaa, additional, Elhabashy, Hala Rashad, additional, Elhadi, Muhammed, additional, Eskandarieh, Sharareh, additional, Etemadimanesh, Azin, additional, Ezati Asar, Mohamad, additional, Falahi, Shahab, additional, Farzadfar, Farshad, additional, Fatehizadeh, Ali, additional, Fattahi, Hamed, additional, Foroutan, Masoud, additional, Ghafourifard, Mansour, additional, Ghamari, Seyyed-Hadi, additional, Ghanbari, Reza, additional, Ghanei Gheshlagh, Reza, additional, Ghashghaee, Ahmad, additional, Gholamalizadeh, Maryam, additional, Ghorbani, Alireza, additional, Gilani, Syed Amir, additional, Gohari, Kimiya, additional, Goleij, Pouya, additional, Grivna, Michal, additional, Gubari, Mohammed Ibrahim Mohialdeen, additional, Haddadi, Rasool, additional, Hafezi-Nejad, Nima, additional, Haj-Mirzaian, Arvin, additional, Halwani, Rabih, additional, Hameed, Sajid, additional, Hanif, Asif, additional, Hasaballah, Ahmed I, additional, Hassan, Amr, additional, Hassanian-Moghaddam, Hossein, additional, Hassanipour, Soheil, additional, Hassankhani, Hadi, additional, Hayat, Khezar, additional, Heidari, Mohammad, additional, Hosseini, Mohammad-Salar, additional, Hosseini, Mostafa, additional, Hosseinzadeh, Mehdi, additional, Househ, Mowafa, additional, Hoveidamanesh, Soodabeh, additional, Huijer, Huda Abu-Saad, additional, Imani, Behzad, additional, Irvani, Seyed Sina Naghibi, additional, Jabbarinejad, Roxana, additional, Jahani, Mohammad Ali, additional, Jalili, Mahsa, additional, Javadi Mamaghani, Amirreza, additional, Jeddi, Seyed Ali, additional, Joukar, Farahnaz, additional, Kabir, Ali, additional, Kalankesh, Laleh R, additional, Kalankesh, Leila R, additional, Kalhor, Rohollah, additional, Kamran, Aziz, additional, Keikavoosi-Arani, Leila, additional, Keykhaei, Mohammad, additional, Khader, Yousef Saleh, additional, Khalilov, Rovshan, additional, Khammarnia, Mohammad, additional, Khan, Ejaz Ahmad, additional, Khan, Maseer, additional, Khan, Moien AB, additional, Khanali, Javad, additional, Khayat Kashani, Hamid Reza, additional, Khosravizadeh, Omid, additional, Kolahi, Ali-Asghar, additional, Koohestani, Hamid Reza, additional, Koolaji, Sogol, additional, Lami, Faris Hasan, additional, Lasrado, Savita, additional, Madadizadeh, Farzan, additional, Magdy Abd El Razek, Muhammed, additional, Mahdavi, Mahdi, additional, Mahjoub, Soleiman, additional, Mahmoodpoor, Ata, additional, Mahmoudi, Razzagh, additional, Makki, Alaa, additional, Malekpour, Mohammad-Reza, additional, Malekzadeh, Reza, additional, Malih, Narges, additional, Malik, Ahmad Azam, additional, Mansour-Ghanaei, Fariborz, additional, Mansouri, Borhan, additional, Mansournia, Mohammad Ali, additional, Masoumi, Seyedeh Zahra, additional, Mehrabi Nasab, Entezar, additional, Menezes, Ritesh G, additional, Mesregah, Mohamed Kamal, additional, Mirmoeeni, Seyyedmohammadsadeq, additional, Mirza-Aghazadeh-Attari, Mohammad, additional, Mohammadi, Esmaeil, additional, Mohammadi, Heidar, additional, Mohammadi, Mokhtar, additional, Mohammadi, Seyyede Momeneh, additional, Mohammadian-Hafshejani, Abdollah, additional, Mohammed, Teroj Abdulrahman, additional, Moludi, Jalal, additional, Momtazmanesh, Sara, additional, Moradi, Maryam, additional, Moradi, Masoud, additional, Moradpour, Farhad, additional, Moradzadeh, Rahmatollah, additional, Mortazavi, Nazanin, additional, Mortazavi, Seyede Salehe, additional, Najafi, Houshang, additional, Najafpour, Zhila, additional, Natto, Zuhair S, additional, Nazari, Javad, additional, Nouraei, Hasti, additional, Nouri, Fatemeh, additional, Okati-Aliabad, Hassan, additional, Omar Bali, Ahmed, additional, Omer, Emad, additional, Pashazadeh Kan, Fatemeh, additional, Pazoki Toroudi, Hamidreza, additional, Piracha, Zahra Zahid, additional, Pourbagher-Shahri, AliMohammad, additional, Pourtaheri, Naeimeh, additional, Rabiee, Mohammad, additional, Rabiee, Navid, additional, Raeghi, Saber, additional, Rafieemehr, Hassan, additional, Rafiei, Sima, additional, Rahim, Fakher, additional, Rahimi-Dehgolan, Shahram, additional, Rahmani, Amir Masoud, additional, Rahmanian, Vahid, additional, Ramezanzadeh, Kiana, additional, Rao, Chythra R, additional, Rashedi, Vahid, additional, Rashidi, Amirfarzan, additional, Rashidi, Mahsa, additional, Rashidi, Mohammad-Mahdi, additional, Rasul, Azad, additional, Rawassizadeh, Reza, additional, Rayegani, Seyed-Mansoor, additional, Rezaei, Nazila, additional, Rezaei, Negar, additional, Rezaei, Saeid, additional, Rezaei, Zahed, additional, Rezaeian, Mohsen, additional, Rezapur-Shahkolai, Forouzan, additional, Rezazadeh-Khadem, Sahba, additional, Saadati, Mohammad, additional, Sabour, Siamak, additional, Saddik, Basema, additional, Saeed, Umar, additional, Saeedi Moghaddam, Sahar, additional, Safarpour, Hamid, additional, Safdarian, Mahdi, additional, Sahebkar, Amirhossein, additional, Salamati, Payman, additional, Salem, Marwa Rashad, additional, Samy, Abdallah M, additional, Sanadgol, Nima, additional, Saqib, Muhammad Arif Nadeem, additional, Sarikhani, Yaser, additional, Sarveazad, Arash, additional, Sathian, Brijesh, additional, Sayyah, Mehdi, additional, Sepanlou, Sadaf G, additional, Shahabi, Saeed, additional, Shaikh, Masood Ali, additional, Shaker, Elaheh, additional, Shams-Beyranvand, Mehran, additional, Sharifian, Sakineh, additional, Shati, Mohsen, additional, Shehata, Hatem Samir, additional, Sheidaei, Ali, additional, Sheikhbahaei, Sara, additional, Sheikhi, Rahim Ali, additional, Shobeiri, Parnian, additional, Siabani, Soraya, additional, Sivandzadeh, Gholam Reza, additional, Sofi-Mahmudi, Ahmad, additional, Sohrabi, Ahmad, additional, Tabaeian, Seidamir Pasha, additional, Tabary, Mohammadreza, additional, Tabibian, Elnaz, additional, Taheri, Ensiyeh, additional, Taheri, Majid, additional, Tehrani-Banihashemi, Arash, additional, Tiyuri, Amir, additional, Tohidast, Seyed Abolfazl, additional, Ullah, Saif, additional, Vahedi, Parviz, additional, Valadan Tahbaz, Sahel, additional, Valizadeh, Rohollah, additional, Varmaghani, Mehdi, additional, Vo, Bay, additional, Waheed, Yasir, additional, Yahyazadeh Jabbari, Seyed Hossein, additional, Yazdanpanah, Fereshteh, additional, Yousefi, Zabihollah, additional, Yusefi, Hossein, additional, Zahirian Moghadam, Telma, additional, Zandian, Hamed, additional, Zare, Iman, additional, Ziapour, Arash, additional, and Mokdad, Ali H, additional

Published
2022
Full Text
View/download PDF

29. The possible double‐edged sword effects of vitamin D on COVID‐19: A hypothesis.

Author

Shojaeefar, Ehsan, Malih, Narges, and Rezaei, Nima

Subjects
*COVID-19, *VITAMIN D, *ANGIOTENSIN converting enzyme, *NADPH oxidase, *CATHELICIDINS
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) gains access to host cells by attaching to angiotensin‐converting enzyme 2 (ACE2). Vitamin D (VitD) can upregulate ACE2 and has an antagonistic effect on Renin, which exerts a vasodilatation and anti‐inflammatory effect against coronavirus disease (COVID‐19). However, it may also facilitate viral entry by increasing ACE2 as the main SARS‐CoV‐2 receptor and mediates ROS production through NADPH oxidase, as a double‐edged sword effect. Lung function and the immune system are also influenced by VitD through several mechanisms, including increased natural antibiotics (Defensin and Cathelicidin) and upregulated transforming growth factor‐β. A higher IgA, Th2/Th1 ratio, and T‐regulatory cells are attributable to VitD effects on the immune cells, while these changes may also be a double‐edged sword in COVID‐19. Although VitD supplementation might be highly recommended in COVID‐19, the administration's dosage and route could be challenging. Furthermore, this issue has not been mentioned in various studies so far. So, the report aimed to explain the current challenges with the application of VitD in COVID‐19. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

33. Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial.

Author

Taheripanah, Robabeh, Shoman, Amal, Karimzadeh, Mohammad Ali, Zamaniyan, Marzieh, and Malih, Narges

Subjects
OXYTOCIN, CLINICAL trials, CESAREAN section, GENERAL anesthesia, RANDOMIZED controlled trials
Abstract

Objective: To compare the use of carbetocin and oxytocin in the prevention of postpartum hemorrhage after cesarean section.Methods: The present study was a prospective double-blind randomized controlled clinical trial performed in two university-based hospitals in Tehran, Iran. Two hundred and twenty women with the gestational age of more than 37 weeks, who needed cesarean operation, participated in the study. Patients were assigned to receive either a single 100 μg IV dose of carbetocin or a standard 30-international unit IV infusion of oxytocin during 2 h after delivery of placenta. The primary outcome measures were postpartum hemorrhage requiring additional uterotonic drugs, bleeding volume, and the hemoglobin drops.Results: There were meaningful differences in carbetocin versus oxytocin group regarding the hemoglobin drops (1.01 versus 2.05, p = .01), bleeding volume (430.68 CC versus 552.6 CC, p < .001), uterine massages frequency (3.7 versus 4.26, p < .001), and uterine height at 2, 4, and 24 h (p < .001). Oxytocin side effects were significantly higher in comparison with the carbetocin except pruritus which was observed in 27% of patients in the carbetocin versus no cases in the oxytocin group.Conclusions: It may be concluded that carbetocin is a good alternative modality to conventional uterotonic agents such as oxytocin for the prevention of postpartum hemorrhage after cesarean sections. Registration ID in IRCT: NCT02079558. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

35. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.

Author

Malih, Sara, Saidijam, Massoud, and Malih, Narges

Abstract

With the development of technologies such as microarrays and RNA deep sequencing, long noncoding RNAs (lncRNAs) have become the focus of cancer investigations. LncRNAs, nonprotein-coding RNA molecules longer than 200 nucleotides, are dysregulated in many human diseases, especially in cancers. Recent studies have demonstrated that lncRNAs play a key regulatory role in gene expression and cancer biology through diverse mechanisms, including chromosome remodeling and transcriptional and post-transcriptional modifications. The expression levels of specific lncRNAs are attributed to prognosis, metastasis, and recurrence of cancer. LncRNAs are often involved in various biological processes, such as regulation of alternative splicing of mRNA, protein activity, and epigenetic modulation or silencing of the microRNAs, via discrete mechanisms. Deregulated levels of lncRNAs are shown in diverse tumors, including breast cancer. Based on latest research data, the tissue-specific expression signature of lncRNAs may represent the potential to discriminate normal and tumor tissue or even the different stages of breast cancer, which makes them clinically beneficial as possible biomarkers in the diagnosis and prognosis or therapeutic targets. In this brief review, we summarize some recent researches in the context of lncRNAs' roles in breast cancer pathogenesis and their potential to serve as diagnostic, predictive, and prognostic biomarkers and novel targets for breast cancer treatment. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

36. Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT.

Author

Taheripanah, Robabeh, Zamaniyan, Marzieh, Moridi, Atefeh, Taheripanah, Anahita, and Malih, Narges

Subjects
*GONADOTROPIN releasing hormone, *OVULATION, *HUMAN artificial insemination, *FEMALE infertility, *DEVELOPMENTAL biology
Abstract

Background: The purpose of triggering in ovulation induction is to induce the final maturation of oocytes and their release from the ovary for fertilization. Objective: The aim of the present study was to compare the effectiveness of gonadotropin-releasing hormone (GnRH) agonist and human chorionic gonadotropin (HCG) on the final maturation of oocytes and pregnancy rates in intrauterine insemination (IUI) cycles. Materials and Methods: In this randomized clinical trial, 110 infertile women who were selected for IUI entered the study. Ovulation induction was performed. Group I received 0.1 mg GnRH agonist as triggering and group II received 10,000 IU of HCG. The serum Estradiol (E2), Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH) levels were measured at 12 and 36 hr after injection. Results: LH surge was detected in all patients. LH levels at 12 and 36 hr after triggering was higher in Group I and it washed out earlier than group II (p=0.00). The pregnancy rate was higher in Group I, but the difference was not statistically significant (26.9% vs. 20.8%, respectively p=0.46). Also, the incidence of ovarian hyperstimulation syndrome was not different between the two groups (p=0.11). There was a significant difference regarding the estradiol levels at 36 hours after triggering (p=0.00). Conclusion: Effects of GnRH on endogenous LH surge is sufficient for oocyte releasing and final follicular maturation. Pregnancy rates and ovarian hyperstimulation syndrome incidence were not different between the groups. We suggest that GnRH agonists might be used as an alternative option instead of HCG in IUI cycles. [ABSTRACT FROM AUTHOR]

Published
2017

37. Does intrauterine saline infusion by intrauterine insemination (IUI) catheter as endometrial injury during IVF cycles improve pregnancy outcomes among patients with recurrent implantation failure?: An RCT.

Author

Salehpour, Saghar, Zamaniyan, Marzieh, Saharkhiz, Nasrin, Zadeh, Shahrzad, Hosieni, Sedighe, Seif, Samira, Malih, Narges, Rezapoor, Parinaz, and Sohrabi, Mohammad-Reza

Subjects
*HUMAN artificial insemination, *ENDOMETRIUM, *SALINE injections, *REPRODUCTIVE technology, *MISCARRIAGE, *WOUNDS & injuries
Abstract

Background: Recurrent implantation failure is one of the most issues in IVF cycles. Some researchers found that beneficial effects of endometrial Scratching in women with recurrent implantation failure, while some authors demonstrated contrary results. Objective: The present study aimed to investigate the effect of intrauterine. Saline infusion as a form of endometrial injury, during fresh in vitro fertilization-embryo transfer cycle, among patients with recurrent implantation failure. Materials and Methods: In this clinical trial study 63 women undergoing assisted reproductive technology were divided into two groups either local endometrial injury by intrauterine saline infusion during day 3-5 of the ongoing controlled ovarian stimulation cycle, or IVF protocol performed without any other intervention in Taleghani Hospital, Tehran, Iran. The main outcome measure was clinical pregnancy rates. Results: Patients who received intra uterine saline infusion (n=20), had significantly lower clinical pregnancy numbers (1 vs. 9, p<0.05) and implantation rates (4.7% vs. 41.6%, p<0.05), compared to controls (n=39). However, there was no significant difference in miscarriage rates (9.4% vs. 8.7%, p>0.05) and multiple pregnancy numbers (1 vs. 3, p>0.05) between groups. Conclusion: When intrauterine saline infusion as a form of endometrial injury is performed during the ongoing IVF cycles it has negative effect on reproductive outcomes among patients with recurrent implantation failure. [ABSTRACT FROM AUTHOR]

Published
2016

38. Reporting of Participant Race and Ethnicity from COVID-19 Randomized Controlled Drug and Biologicals Trials: A Scoping Review.

Author

Pranić SM, Estevão MD, Vasanthan LT, Pérez-Neri I, Pulumati A, de Lima Junior FAS, Malih N, Mishra V, Thompson J, and Nnate D

Abstract

Racial and ethnic minorities have been disproportionally burdened by hospitalization and death due to COVID-19. Participation of individuals of diverse races and ethnicities in clinical trials according to study-level characteristics of randomized controlled trials (RCT) that test effectiveness of COVID-19 drugs could be insightful for future researchers. The objective of this scoping review was to describe frequency of race and ethnicity reported as demographic variables and specific reporting of race and ethnicity according to COVID-19 RCT characteristics. We conducted comprehensive searches in Pubmed, ProQuest, WHO Database, and Cochrane Central Register of Controlled Trials, and gray literature via preprint servers from 1/1/2020 to 5/4/2022. We included RCTs on emergency- or conditionally-approved COVID-19 drug interventions (remdesivir, baricitinib, and molnupiravir) with or without comparators. Self-reported race as American Indian/Pacific Islander, Asian, Black/African American, or White, ethnicity as Hispanic/Latinx, study design characteristics, and participant-relevant data were collected. A total of 17 RCTs with 17935 participants was included. Most (n=13, 76%) reported at least one race and ethnicity and were US-based, industry-funded RCTs. Asian, Black, Latinx, and White participants were mostly enrolled in RCTs that studied remdesivir. Native American and Hawaiian participants were mostly assessed for progression to high-flow oxygen/non-invasive ventilation. Time to recovery was assessed predominantly in Black and White participants, while hospitalization or death was mostly assessed in Asian, Latinx, and multi-race participants. Trialists should be aware of RCT-level factors and characteristics that may be associated with low participation of racial and ethnic minorities, which could inform evidence-based interventions to increase minority participation., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Published
2024
Full Text
View/download PDF

39. The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma.

Author

Agache I, Ricci-Cabello I, Canelo-Aybar C, Annesi-Maesano I, Cecchi L, Biagioni B, Chung KF, D'Amato G, Damialis A, Del Giacco S, De Las Vecillas L, Dominguez-Ortega J, Galán C, Gilles S, Giovannini M, Holgate S, Jeebhay M, Nadeau K, Papadopoulos N, Quirce S, Sastre J, Traidl-Hoffmann C, Walusiak-Skorupa J, Salazar J, Sousa-Pinto B, Colom M, Fiol-deRoque MA, Gorreto López L, Malih N, Moro L, Pardo MG, Pazo PG, Campos RZ, Saletti-Cuesta L, Akdis M, Alonso-Coello P, Jutel M, and Akdis CA

Subjects
Humans, Pregnancy, Practice Guidelines as Topic, Environmental Exposure adverse effects, Female, Asthma etiology, Asthma prevention & control, Tobacco Smoke Pollution adverse effects, Electronic Nicotine Delivery Systems
Abstract

To inform the clinical practice guidelines' recommendations developed by the European Academy of Allergy and Clinical Immunology systematic reviews (SR) assessed using GRADE on the impact of environmental tobacco smoke (ETS) and active smoking on the risk of new-onset asthma/recurrent wheezing (RW)/low lung function (LF), and on asthma-related outcomes. Only longitudinal studies were included, almost all on combustion cigarettes, only one assessing e-cigarettes and LF. According to the first SR (67 studies), prenatal ETS increases the risk of RW (moderate certainty evidence) and may increase the risk of new-onset asthma and of low LF (low certainty evidence). Postnatal ETS increases the risk of new-onset asthma and of RW (moderate certainty evidence) and may impact LF (low certainty evidence). Combined in utero and postnatal ETS may increase the risk of new-onset asthma (low certainty evidence) and increases the risk of RW (moderate certainty evidence). According to the second SR (24 studies), ETS increases the risk of severe asthma exacerbations and impairs asthma control and LF (moderate certainty evidence). According to the third SR (25 studies), active smoking increases the risk of severe asthma exacerbations and of suboptimal asthma control (moderate certainty evidence) and may impact asthma-related quality-of-life and LF (low certainty evidence)., (© 2024 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.)

Published
2024
Full Text
View/download PDF

40. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.

Author

Malih S, Saidijam M, and Malih N

Subjects
Breast Neoplasms diagnosis, Breast Neoplasms therapy, Female, Humans, Biomarkers, Tumor genetics, Breast Neoplasms genetics, RNA, Long Noncoding genetics
Abstract

With the development of technologies such as microarrays and RNA deep sequencing, long noncoding RNAs (lncRNAs) have become the focus of cancer investigations. LncRNAs, nonprotein-coding RNA molecules longer than 200 nucleotides, are dysregulated in many human diseases, especially in cancers. Recent studies have demonstrated that lncRNAs play a key regulatory role in gene expression and cancer biology through diverse mechanisms, including chromosome remodeling and transcriptional and post-transcriptional modifications. The expression levels of specific lncRNAs are attributed to prognosis, metastasis, and recurrence of cancer. LncRNAs are often involved in various biological processes, such as regulation of alternative splicing of mRNA, protein activity, and epigenetic modulation or silencing of the microRNAs, via discrete mechanisms. Deregulated levels of lncRNAs are shown in diverse tumors, including breast cancer. Based on latest research data, the tissue-specific expression signature of lncRNAs may represent the potential to discriminate normal and tumor tissue or even the different stages of breast cancer, which makes them clinically beneficial as possible biomarkers in the diagnosis and prognosis or therapeutic targets. In this brief review, we summarize some recent researches in the context of lncRNAs' roles in breast cancer pathogenesis and their potential to serve as diagnostic, predictive, and prognostic biomarkers and novel targets for breast cancer treatment.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results